BRAF with or without MEK inhibition plus PD-1 checkpoint blockade for the treatment of metastatic melanoma.

被引：1
|
作者：
Rohlfs, Michelle [1 ]
Bassett, Roland L. [1 ]
Lacey, Carol [1 ]
McQuail, Natalie [1 ]
Mehta, Urvi [1 ]
John, Ida [1 ]
Simien, Rinata [1 ]
Tupue, Stephanie [1 ]
Dett, Tina Karin [1 ]
Glitza, Isabella Claudia [1 ]
Diab, Adi [1 ]
Amaria, Rodabe Navroze [1 ]
Tawbi, Hussein Abdul-Hassan [1 ]
Davies, Michael A. [1 ]
Hwu, Wen-Jen [1 ]
Hwu, Patrick [1 ]
Patel, Sapna Pradyuman [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.9548
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9548
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
    Ribas, Antoni
    Lawrence, Donald
    Atkinson, Victoria
    Agarwal, Sachin
    Miller, Wilson H., Jr.
    Carlino, Matteo S.
    Fisher, Rosalie
    Long, Georgina V.
    Hodi, F. Stephen
    Tsoi, Jennifer
    Grasso, Catherine S.
    Mookerjee, Bijoyesh
    Zhao, Qing
    Ghori, Razi
    Moreno, Blanca Homet
    Ibrahim, Nageatte
    Hamid, Omid
    NATURE MEDICINE, 2019, 25 (06) : 936 - +
  • [2] Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
    Antoni Ribas
    Donald Lawrence
    Victoria Atkinson
    Sachin Agarwal
    Wilson H. Miller
    Matteo S. Carlino
    Rosalie Fisher
    Georgina V. Long
    F. Stephen Hodi
    Jennifer Tsoi
    Catherine S. Grasso
    Bijoyesh Mookerjee
    Qing Zhao
    Razi Ghori
    Blanca Homet Moreno
    Nageatte Ibrahim
    Omid Hamid
    Nature Medicine, 2019, 25 : 936 - 940
  • [3] Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
    Antoni Ribas
    Donald Lawrence
    Victoria Atkinson
    Sachin Agarwal
    Wilson H. Miller
    Matteo S. Carlino
    Rosalie Fisher
    Georgina V. Long
    F. Stephen Hodi
    Jennifer Tsoi
    Catherine S. Grasso
    Bijoyesh Mookerjee
    Qing Zhao
    Razi Ghori
    Blanca Homet Moreno
    Nageatte Ibrahim
    Omid Hamid
    Nature Medicine, 2019, 25 : 1319 - 1319
  • [4] Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
    Ascierto, Paolo A.
    Capone, Mariaelena
    Grimaldi, Antonio M.
    Mallardo, Domenico
    Simeone, Ester
    Madonna, Gabriele
    Roder, Heinrich
    Meyer, Krista
    Asmellash, Senait
    Oliveira, Carlos
    Roder, Joanna
    Grigorieva, Julia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] Outcomes following progression on BRAF/MEK inhibition in metastatic melanoma.
    Mason, Robert
    Heng, Sharon
    Atkinson, Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma
    Callahan, Margaret K.
    Chapman, Paul B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (13) : 1393 - +
  • [7] Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma (vol 25, pg 936, 2019)
    Ribas, Antoni
    Lawrence, Donald
    Atkinson, Victoria
    Agarwal, Sachin
    Miller, Wilson H., Jr.
    Carlino, Matteo S.
    Fisher, Rosalie
    Long, Georgina V.
    Hodi, F. Stephen
    Tsoi, Jennifer
    Grasso, Catherine S.
    Mookerjee, Bijoyesh
    Zhao, Qing
    Ghori, Razi
    Moreno, Blanca Homet
    Ibrahim, Nageatte
    Hamid, Omid
    NATURE MEDICINE, 2019, 25 (08) : 1319 - 1319
  • [8] Triplet combination of BRAF, MEK and PD-1/PD-L1 blockade in melanoma: the more the better?
    Trojaniello, Claudia
    Vitale, Maria G.
    Ascierto, Paolo A.
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (02) : 133 - 138
  • [9] Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy
    Saab, Karim
    Mooradian, Meghan
    Wang, Daniel Ying
    Chon, Jeewon
    Xia, Cathy Yi
    Bialczak, Angelica
    Abbate, Kelly
    Menzies, Alexander M.
    Johnson, Douglas Buckner
    Sullivan, Ryan J.
    Shoushtari, Alexander Noor
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Dual immunotherapy targeting macrophages and PD-1 immune checkpoint for treatment of melanoma.
    Shudde, Claire E.
    Patel, Jalpa
    Rajan, Robin
    Shmeeda, Hilary
    Dung Nguyen
    Gabizon, Alberto A.
    La-Beck, Ninh M.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 96 - 96
12345